Global HER2 Testing Supply, Demand and Key Producers, 2023-2029

Global HER2 Testing Supply, Demand and Key Producers, 2023-2029

The global HER2 Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global HER2 Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for HER2 Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of HER2 Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global HER2 Testing total market, 2018-2029, (USD Million)

Global HER2 Testing total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: HER2 Testing total market, key domestic companies and share, (USD Million)

Global HER2 Testing revenue by player and market share 2018-2023, (USD Million)

Global HER2 Testing total market by Type, CAGR, 2018-2029, (USD Million)

Global HER2 Testing total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global HER2 Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Leica Biosystems (Danaher Corporation), Empire Genomics, Inc. (Biocare Medical,LLC), Bio-Genex Laboratories, Abnova Corporation and Oxford Gene Technology IP Limited(Sysmex Corporation), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HER2 Testing market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global HER2 Testing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global HER2 Testing Market, Segmentation by Type
Breast Cancer
Stomach Cancer

Global HER2 Testing Market, Segmentation by Application
Hospital
Diagnostic Laboratory
Other

Companies Profiled:
Abbott
Hoffmann-La Roche Ltd
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Leica Biosystems (Danaher Corporation)
Empire Genomics, Inc. (Biocare Medical,LLC)
Bio-Genex Laboratories
Abnova Corporation
Oxford Gene Technology IP Limited(Sysmex Corporation)

Key Questions Answered

1. How big is the global HER2 Testing market?

2. What is the demand of the global HER2 Testing market?

3. What is the year over year growth of the global HER2 Testing market?

4. What is the total value of the global HER2 Testing market?

5. Who are the major players in the global HER2 Testing market?

6. What are the growth factors driving the market demand?